Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mazyar Shadman

Showing results (51-60 of 224) with videos related to

Pageof 23
Sort By:
Hemasphere|August 18, 2020
How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS-CoV-2 PandemicDavide Rossi, Mazyar Shadman, Adalgisa Condoluci, et al.
Ejhaem|December 18, 2024
A phase 2 study of frontline pembrolizumab in follicular lymphomaCarrie Ho, Songli Zhu, Ted Gooley, et al.
Transfusion|May 9, 2012
Transfusion-associated graft-versus-host disease in a liver transplant recipient: an unusual presentation and review of the literatureKerry L O'Brien, Shalini E Pereira, Jeffrey Wagner, et al.
Nutrition and Cancer|May 21, 2011
Colorectal polyp type and the association with charred meat consumption, smoking, and microsomal epoxide hydrolase polymorphismsAndrea N Burnett-Hartman, Polly A Newcomb, Margaret T Mandelson, et al.
Haematologica|July 3, 2025
Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemo-immunotherapy on the SWOG S0016 trialAlexey V Danilov, Hongli Li, Mazyar Shadman, et al.
Blood Advances|April 9, 2025
Comparative efficacy of Bruton tyrosine kinase inhibitors in high-risk relapsed/refractory CLL: a network meta-analysisMazyar Shadman, Jennifer R Brown, Leyla Mohseninejad, et al.
Blood Advances|January 26, 2026
An Indirect Comparison of Zanubrutinib vs Acalabrutinib Plus Venetoclax in Patients With Treatment-Naive CLLMazyar Shadman, Constantine S Tam, Danielle M Brander, et al.
American Journal of Hematology|May 2, 2020
Management of CLL patients early in the COVID-19 pandemic: An international survey of CLL expertsBrian Koffman, Anthony Mato, John C Byrd, et al.
Current Medical Research and Opinion|September 27, 2023
Health-related quality-of-life in treatment-naive CLL/SLL patients treated with zanubrutinib versus bendamustine plus rituximabPaolo Ghia, Gisoo Barnes, Keri Yang, et al.
Transplantation and Cellular Therapy|October 25, 2025
Who Is Eligible for Chimeric Antigen Receptor T Cell Therapy? Expert Perspectives on Overcoming Referral BarriersMazyar Shadman, Sairah Ahmed, Michael T Byrne, et al.
Pageof 23

Showing results (51-60 of 224) with videos related to

Sort By:
Pageof 23
Hemasphere|August 18, 2020
How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS-CoV-2 PandemicDavide Rossi, Mazyar Shadman, Adalgisa Condoluci, et al.
Ejhaem|December 18, 2024
A phase 2 study of frontline pembrolizumab in follicular lymphomaCarrie Ho, Songli Zhu, Ted Gooley, et al.
Transfusion|May 9, 2012
Transfusion-associated graft-versus-host disease in a liver transplant recipient: an unusual presentation and review of the literatureKerry L O'Brien, Shalini E Pereira, Jeffrey Wagner, et al.
Nutrition and Cancer|May 21, 2011
Colorectal polyp type and the association with charred meat consumption, smoking, and microsomal epoxide hydrolase polymorphismsAndrea N Burnett-Hartman, Polly A Newcomb, Margaret T Mandelson, et al.
Haematologica|July 3, 2025
Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemo-immunotherapy on the SWOG S0016 trialAlexey V Danilov, Hongli Li, Mazyar Shadman, et al.
Blood Advances|April 9, 2025
Comparative efficacy of Bruton tyrosine kinase inhibitors in high-risk relapsed/refractory CLL: a network meta-analysisMazyar Shadman, Jennifer R Brown, Leyla Mohseninejad, et al.
Blood Advances|January 26, 2026
An Indirect Comparison of Zanubrutinib vs Acalabrutinib Plus Venetoclax in Patients With Treatment-Naive CLLMazyar Shadman, Constantine S Tam, Danielle M Brander, et al.
American Journal of Hematology|May 2, 2020
Management of CLL patients early in the COVID-19 pandemic: An international survey of CLL expertsBrian Koffman, Anthony Mato, John C Byrd, et al.
Current Medical Research and Opinion|September 27, 2023
Health-related quality-of-life in treatment-naive CLL/SLL patients treated with zanubrutinib versus bendamustine plus rituximabPaolo Ghia, Gisoo Barnes, Keri Yang, et al.
Transplantation and Cellular Therapy|October 25, 2025
Who Is Eligible for Chimeric Antigen Receptor T Cell Therapy? Expert Perspectives on Overcoming Referral BarriersMazyar Shadman, Sairah Ahmed, Michael T Byrne, et al.
Pageof 23